Health Care/Hospital

Ministry of Tourism and Creative Economy Will Implement CHS Program in Destinations, Bali Becomes the Pilot Project

BALI, Indonesia, May 25, 2020 /PRNewswire/ -- Ministry of Tourism and Creative Economy is going to implement CHS (Cleanliness, Health, and Safety) program in every destination and other locations related to tourism and creative economy as a strategy to accelerate...

2020-05-25 19:01 9488

China's medical rehabilitation market likely to see significant growth potential, five key sub-sectors identified, finds KPMG report

HONG KONG, May 25, 2020 /PRNewswire/ -- With increasing importance placed on medical rehabilitation, KPMG has identified five out of eleven rehabilitation sub-sectors with the highest potential in terms of their market attractiveness and market entry abilities. These are neurological rehabilitati...

2020-05-25 18:40 2555

Penta Security Expands Presence in Singapore Healthcare Sector with Identity and Access Management (IAM) Solution

SINGAPORE, May 25, 2020 /PRNewswire/ -- Penta Security, the first appliance-type identity and access management (IAM) solution provider inSouth Korea, expanded into Singapore through a contract with a leading healthcare technology company that specializes in benefits administration for employees....

2020-05-25 17:01 5766

Guide Infrared Reports 20-Fold Q1 Revenue Growth Amid Sluggish Economy

WUHAN, China, May 25, 2020 /PRNewswire/ -- Guide Infrared ("the Company"), a leading Chinese manufacturer of infrared thermal imaging systems based in China Optical Valley, has released its first-quarter earnings snapshot. In the first quarter, Guide Infrared is expected to book a profit of 17 mi...

2020-05-25 16:15 3561

New Late-Breaking Data at EAN Indicate Evobrutinib is the First BTK Inhibitor to Report Efficacy and Safety in MS Over 108 Weeks

- Not intended for UK and U.S. based media - Investigational evobrutinib is the first and only Bruton's Tyrosine Kinase inhibitor to demonstrate high and sustained efficacy through 108 weeks in clinical studies  - No new safety signals identified in the 60 week open-label extension, consistent ...

2020-05-25 08:18 2211

HistoIndex's AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China

SINGAPORE, May 25, 2020 /PRNewswire/ -- Singapore medtech company HistoIndex 's AI-based stain-free digital pathology platform has long been established as a suitable tool for global clinical guidelines that outline the assessment, prevention and treatment of Chronic ...

2020-05-25 06:00 3431

Safe Spacer™ wearable social distance monitor/alarm helps keep people safe and workplaces or public spaces open

MODENA, Italy, May 23, 2020 /PRNewswire/ -- Safe Spacer™ is a lightweight wearable device that helps workers and visitors to maintain safe social distancing, enabling workplaces and public spaces to re-open and operate with peace of mind. 

2020-05-23 07:07 5617

VolitionRx Announces Closing of $13.8 Million Public Offering of Common Stock

AUSTIN, Texas, May 22, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its NucleosomicsTM platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to hel...

2020-05-23 04:01 11315

Dr. Rajamannan Reports to Northwestern University, Chicago IL VP: COVID-19 Non-Compliance in Clinical Trials

COVID-19 - The letter to the VP for Research SHEBOYGAN, Wisconsin, May 22, 2020 /PRNewswire/ -- Most Sacred Heart of Jesus Cardiology and Valvular Institute Director Dr. Nalini Rajamannan, has submitted evidence in an open letter toNorthwestern University's Newly Minted Vice President for Resea...

2020-05-22 23:13 3613

MEDI FUTURES designated as "Global ICT Future Unicorn"

SEOUL, South Korea, May 22, 2020 /PRNewswire/ -- MEDI FUTURES, a biomedical ultrasound company, was designated by the Korean government as a "Global ICT Future Unicorn." MEDI FUTURES has been an active member of theBorn2Global Centre . MEDI F...

2020-05-22 16:15 4018

Mayne Pharma launches BAC 300 capsules in the United States

ADELAIDE, Australia, May 22, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce the launch of butalbital acetaminophen and caffeine (BAC) capsule 50mg/300mg/40mg inthe United States. Mayne Pharma received approval from the US Food and Drug Administration for its Abb...

2020-05-22 13:44 5648

Nippon Express (UK) Receives WDA and GDP Certification for Company Warehouse near London Heathrow Airport

TOKYO, May 22, 2020 /PRNewswire/ -- Nippon Express (UK) Co., Ltd. (hereinafter, "NEUK"), a local subsidiary of Nippon Express Co., Ltd. based inTokyo, has been officially granted Wholesale Distribution Authorisation (WDA) and Good Distribution Practice (GDP) certification for its warehouse near L...

2020-05-22 13:00 1491

GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio

LONDON and SONGDO, South Korea, May 21, 2020 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Samsung Biologics (207940.KS) have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK's innovative biopharmaceutical therapies. Under the terms of th...

2020-05-22 07:11 6464

Solve M.E. Announces Oved Amitay as President and Chief Executive Officer

Global Healthcare Industry Veteran Plans to Leverage Extensive Advocacy Experience, Rare Disease Expertise, and a History of Creating Important Public-Private Partnerships to Benefit ME/CFS Patients; Timing Could Not Be More Critical LOS ANGELES, May 22, 2020 /PRNewswire/ -- Solve M.E., the lead...

2020-05-22 02:00 2703

Frost & Sullivan Analyzes the Future of Adhesion Prevention Products in the US and EU5

Film-type APP is expected to have the largest share of the total APP market, followed by gel-based products SANTA CLARA, California, May 21, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Growth Opportunities for Adhesion Prevention Products Market in US and EU5, Forecast to 2024, predi...

2020-05-21 23:50 2719

Transcenta Announces to Present Preclinical Data of TST001 at 2020 AACR Virtual Annual Meeting II

SUZHOU, China, May 21, 2020 /PRNewswire/ -- Transcenta, a global biotherapeutics company that fully integrates antibody-based biotherapeutics discovery, development and manufacturing, today announced that it will present preclinical data of TST001, a humanized Claudin 18.2 (CLDN18.2) monoclonal ...

2020-05-21 23:00 1614

FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy (Pre-Clinical Trial Phase)

PneumoBlast™ Reduces Pathology and Lung Fluid Accumulation in Model of COVID-19 HOUSTON, May 21, 2020 /PRNewswire/ -- FibroGenesis announced today significant efficacy of its PneumoBlast™ product in an animal model of lung inflammation which resembles COVID-19.  Mice immune systems were stimulate...

2020-05-21 22:03 2945

FibroGenesis Reports COVID-19 Breakthrough Using Fibroblast Cell Therapy (Pre-Clinical Trial Phase)

PneumoBlast™ Reduces Pathology and Lung Fluid Accumulation in Model of COVID-19 HOUSTON, May 21, 2020 /PRNewswire/ -- FibroGenesis announced today significant efficacy of its PneumoBlast™ product in an animal model of lung inflammation which resembles COVID-19.  Mice immune systems were stimulate...

2020-05-21 22:03 2324

100+ Experts Identified Top Threats and Opportunities for Global Health Just Before COVID-19 Emerged as the First Test of the Medicines Supply Chain

New U.S. Pharmacopeia and MIT Center for Collective Intelligence report examines outlook for the future of medical breakthroughs ROCKVILLE, Md., May 21, 2020 /PRNewswire/ -- Just a few weeks before the first cases of COVID-19 were made public, a group of more than 100 leaders in health and medici...

2020-05-21 20:32 442

Ally Bridge Group Leads US$150 million Financing for Three U.S. Companies Amidst the COVID-19 Pandemic

NEW YORK and HONG KONG, May 21, 2020 /PRNewswire/ -- Ally Bridge Group ("ABG"), a leading global life science investment group, has announced that it led three investments in the U.S. -- two medtech and one telehealth -- in April, 2020 amidst the COVID-19 pandemic. Each of the three companies is ...

2020-05-21 20:00 9876
1 ... 771772773774775776777 ... 847

Week's Top Stories